Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents
Jun Zou, Alexis Bretin, Andrew T. Gewirtz
doi: https://doi.org/10.1101/2020.05.01.20087478
Jun Zou
Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA
Alexis Bretin
Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA
Andrew T. Gewirtz
Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA
Article usage
Posted May 06, 2020.
Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents
Jun Zou, Alexis Bretin, Andrew T. Gewirtz
medRxiv 2020.05.01.20087478; doi: https://doi.org/10.1101/2020.05.01.20087478
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2876)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12600)
- Forensic Medicine (10)
- Gastroenterology (810)
- Genetic and Genomic Medicine (4473)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4231)
- Nursing (226)
- Nutrition (619)
- Oncology (2217)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6817)
- Radiology and Imaging (1501)
- Respiratory Medicine (906)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)